Does Rallies show 13F holders for CME?

Yes. Rallies tracks hedge fund and 13F ownership data for CME, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CME research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CME. It does not provide personalized investment advice.

CME (CME Group) Stock Analysis - Hedge Fund Holdings

CME Group (CME) is a publicly traded Financial Services sector company. As of May 20, 2026, CME trades at $290.39 with a market cap of $110.56B and a P/E ratio of 24.74. CME moved -4.05% today. Year to date, CME is +5.48%; over the trailing twelve months it is +4.41%. Its 52-week range spans $213.94 to $329.16. Analyst consensus is neutral with an average price target of $304.20. Rallies surfaces CME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CME stock?

Hedge funds tracked by Rallies that own CME include GQG Partners, Viking Global, Pinebridge Investments, Bridgewater Associates, and Soros Fund. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CME Group.

CME Key Metrics

Key financial metrics for CME
Metric	Value
Price	$290.39
Market Cap	$110.56B
P/E Ratio	24.74
EPS	$11.80
Dividend Yield	1.30%
52-Week High	$329.16
52-Week Low	$213.94
Volume	2.06M
Avg Volume	0
Revenue (TTM)	$6.76B
Net Income	$4.27B
Gross Margin	0.00%

Top Hedge Funds Holding CME

GQG Partners holds 2.63M shares of CME, changed -37.61% as of Mar 31, 2026.
Viking Global holds 597.37K shares of CME, changed +0.00% as of Jun 30, 2025.
Pinebridge Investments holds 208.90K shares of CME, changed +30.73% as of Sep 30, 2025.
Bridgewater Associates holds 98.46K shares of CME, changed +0.00% as of Dec 31, 2023.
Soros Fund holds 30.03K shares of CME, changed +0.00% as of Mar 31, 2026.

Latest CME News

CME Group Flags Hyperliquid’s $21.5B Oil Futures Volume Over KYC-Free Integrity Fears — May 15, 2026
CME Group’s FedWatch Odds at 71% for Hike by March; Presses Hyperliquid Oversight — May 15, 2026
CME Group’s FedWatch Tool Doubles December Hike Odds to 40% — May 15, 2026
CME Group to Launch Market-Cap Weighted Crypto Index Futures with Micro Contracts — May 14, 2026
CME Group Plans GPU-Hour Futures Contract to Benchmark AI Compute — May 12, 2026

Recent CME Insider Trades

DUFFY TERRENCE A sold 26.00K (~$7.75M) on May 15, 2026.
DUFFY TERRENCE A sold 9.00K (~$2.70M) on May 15, 2026.
SHEPARD WILLIAM R bought 1.41K (~$418.65K) on Mar 26, 2026.

CME Analyst Consensus

12 analysts cover CME: 0 strong buy, 4 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $304.20.

Common questions about CME

Who owns CME stock?: Hedge funds tracked by Rallies that own CME include GQG Partners, Viking Global, Pinebridge Investments, Bridgewater Associates, and Soros Fund. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CME Group.
Does Rallies show 13F holders for CME?: Yes. Rallies tracks hedge fund and 13F ownership data for CME, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CME research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CME. It does not provide personalized investment advice.